Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.
Westin J, Nyholm D, Pålhagen S, Willows T, Groth T, Dougherty M, Karlsson MO. Westin J, et al. Among authors: palhagen s. Clin Neuropharmacol. 2011 Mar-Apr;34(2):61-5. doi: 10.1097/WNF.0b013e31820b570a. Clin Neuropharmacol. 2011. PMID: 21297456 Clinical Trial.
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
Pålhagen SE, Sydow O, Johansson A, Nyholm D, Holmberg B, Widner H, Dizdar N, Linder J, Hauge T, Jansson R, Bergmann L, Kjellander S, Marshall TS. Pålhagen SE, et al. Parkinsonism Relat Disord. 2016 Aug;29:17-23. doi: 10.1016/j.parkreldis.2016.06.002. Epub 2016 Jun 4. Parkinsonism Relat Disord. 2016. PMID: 27318707 Free article.
Selegiline slows the progression of the symptoms of Parkinson disease.
Pålhagen S, Heinonen E, Hägglund J, Kaugesaar T, Mäki-Ikola O, Palm R; Swedish Parkinson Study Group. Pålhagen S, et al. Neurology. 2006 Apr 25;66(8):1200-6. doi: 10.1212/01.wnl.0000204007.46190.54. Epub 2006 Mar 15. Neurology. 2006. PMID: 16540603 Clinical Trial.
EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
Martinez-Martin P, Reddy P, Katzenschlager R, Antonini A, Todorova A, Odin P, Henriksen T, Martin A, Calandrella D, Rizos A, Bryndum N, Glad A, Dafsari HS, Timmermann L, Ebersbach G, Kramberger MG, Samuel M, Wenzel K, Tomantschger V, Storch A, Reichmann H, Pirtosek Z, Trost M, Svenningsson P, Palhagen S, Volkmann J, Chaudhuri KR. Martinez-Martin P, et al. Among authors: palhagen s. Mov Disord. 2015 Apr;30(4):510-6. doi: 10.1002/mds.26067. Epub 2014 Nov 10. Mov Disord. 2015. PMID: 25382161 Clinical Trial.
38 results